Global Norovirus Vaccine Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Norovirus Vaccine Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Norovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Bivalent
  • 1.2.3 Quadrivalent
  • 1.2.4 Hexavalent
• 1.3 Market by Application
  • 1.3.1 Global Norovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Norovirus Vaccine Sales Estimates and Forecasts 2018-2029
• 2.2 Global Norovirus Vaccine Revenue by Region
  • 2.2.1 Global Norovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
  • 2.2.2 Global Norovirus Vaccine Revenue by Region (2018-2023)
  • 2.2.3 Global Norovirus Vaccine Revenue by Region (2024-2029)
  • 2.2.4 Global Norovirus Vaccine Revenue Market Share by Region (2018-2029)
• 2.3 Global Norovirus Vaccine Sales Estimates and Forecasts 2018-2029
• 2.4 Global Norovirus Vaccine Sales by Region
  • 2.4.1 Global Norovirus Vaccine Sales by Region: 2018 VS 2022 VS 2029
  • 2.4.2 Global Norovirus Vaccine Sales by Region (2018-2023)
  • 2.4.3 Global Norovirus Vaccine Sales by Region (2024-2029)
  • 2.4.4 Global Norovirus Vaccine Sales Market Share by Region (2018-2029)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

• 3.1 Global Norovirus Vaccine Sales by Manufacturers
  • 3.1.1 Global Norovirus Vaccine Sales by Manufacturers (2018-2023)
  • 3.1.2 Global Norovirus Vaccine Sales Market Share by Manufacturers (2018-2023)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Norovirus Vaccine in 2022
• 3.2 Global Norovirus Vaccine Revenue by Manufacturers
  • 3.2.1 Global Norovirus Vaccine Revenue by Manufacturers (2018-2023)
  • 3.2.2 Global Norovirus Vaccine Revenue Market Share by Manufacturers (2018-2023)
  • 3.2.3 Global Top 10 and Top 5 Companies by Norovirus Vaccine Revenue in 2022
• 3.3 Global Key Players of Norovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
• 3.4 Global Norovirus Vaccine Sales Price by Manufacturers
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Norovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Norovirus Vaccine, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Norovirus Vaccine, Product Offered and Application
• 3.8 Global Key Manufacturers of Norovirus Vaccine, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Norovirus Vaccine Sales by Type
  • 4.1.1 Global Norovirus Vaccine Historical Sales by Type (2018-2023)
  • 4.1.2 Global Norovirus Vaccine Forecasted Sales by Type (2024-2029)
  • 4.1.3 Global Norovirus Vaccine Sales Market Share by Type (2018-2029)
• 4.2 Global Norovirus Vaccine Revenue by Type
  • 4.2.1 Global Norovirus Vaccine Historical Revenue by Type (2018-2023)
  • 4.2.2 Global Norovirus Vaccine Forecasted Revenue by Type (2024-2029)
  • 4.2.3 Global Norovirus Vaccine Revenue Market Share by Type (2018-2029)
• 4.3 Global Norovirus Vaccine Price by Type
  • 4.3.1 Global Norovirus Vaccine Price by Type (2018-2023)
  • 4.3.2 Global Norovirus Vaccine Price Forecast by Type (2024-2029)

5 Market Size by Application

• 5.1 Global Norovirus Vaccine Sales by Application
  • 5.1.1 Global Norovirus Vaccine Historical Sales by Application (2018-2023)
  • 5.1.2 Global Norovirus Vaccine Forecasted Sales by Application (2024-2029)
  • 5.1.3 Global Norovirus Vaccine Sales Market Share by Application (2018-2029)
• 5.2 Global Norovirus Vaccine Revenue by Application
  • 5.2.1 Global Norovirus Vaccine Historical Revenue by Application (2018-2023)
  • 5.2.2 Global Norovirus Vaccine Forecasted Revenue by Application (2024-2029)
  • 5.2.3 Global Norovirus Vaccine Revenue Market Share by Application (2018-2029)
• 5.3 Global Norovirus Vaccine Price by Application
  • 5.3.1 Global Norovirus Vaccine Price by Application (2018-2023)
  • 5.3.2 Global Norovirus Vaccine Price Forecast by Application (2024-2029)

6 US & Canada

• 6.1 US & Canada Norovirus Vaccine Market Size by Type
  • 6.1.1 US & Canada Norovirus Vaccine Sales by Type (2018-2029)
  • 6.1.2 US & Canada Norovirus Vaccine Revenue by Type (2018-2029)
• 6.2 US & Canada Norovirus Vaccine Market Size by Application
  • 6.2.1 US & Canada Norovirus Vaccine Sales by Application (2018-2029)
  • 6.2.2 US & Canada Norovirus Vaccine Revenue by Application (2018-2029)
• 6.3 US & Canada Norovirus Vaccine Market Size by Country
  • 6.3.1 US & Canada Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
  • 6.3.2 US & Canada Norovirus Vaccine Sales by Country (2018-2029)
  • 6.3.3 US & Canada Norovirus Vaccine Revenue by Country (2018-2029)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Norovirus Vaccine Market Size by Type
  • 7.1.1 Europe Norovirus Vaccine Sales by Type (2018-2029)
  • 7.1.2 Europe Norovirus Vaccine Revenue by Type (2018-2029)
• 7.2 Europe Norovirus Vaccine Market Size by Application
  • 7.2.1 Europe Norovirus Vaccine Sales by Application (2018-2029)
  • 7.2.2 Europe Norovirus Vaccine Revenue by Application (2018-2029)
• 7.3 Europe Norovirus Vaccine Market Size by Country
  • 7.3.1 Europe Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 Europe Norovirus Vaccine Sales by Country (2018-2029)
  • 7.3.3 Europe Norovirus Vaccine Revenue by Country (2018-2029)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Norovirus Vaccine Market Size
  • 8.1.1 China Norovirus Vaccine Sales (2018-2029)
  • 8.1.2 China Norovirus Vaccine Revenue (2018-2029)
• 8.2 China Norovirus Vaccine Market Size by Application
  • 8.2.1 China Norovirus Vaccine Sales by Application (2018-2029)
  • 8.2.2 China Norovirus Vaccine Revenue by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia Norovirus Vaccine Market Size by Type
  • 9.1.1 Asia Norovirus Vaccine Sales by Type (2018-2029)
  • 9.1.2 Asia Norovirus Vaccine Revenue by Type (2018-2029)
• 9.2 Asia Norovirus Vaccine Market Size by Application
  • 9.2.1 Asia Norovirus Vaccine Sales by Application (2018-2029)
  • 9.2.2 Asia Norovirus Vaccine Revenue by Application (2018-2029)
• 9.3 Asia Norovirus Vaccine Sales by Region
  • 9.3.1 Asia Norovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
  • 9.3.2 Asia Norovirus Vaccine Revenue by Region (2018-2029)
  • 9.3.3 Asia Norovirus Vaccine Sales by Region (2018-2029)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Norovirus Vaccine Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Norovirus Vaccine Sales by Type (2018-2029)
  • 10.1.2 Middle East, Africa and Latin America Norovirus Vaccine Revenue by Type (2018-2029)
• 10.2 Middle East, Africa and Latin America Norovirus Vaccine Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Norovirus Vaccine Sales by Application (2018-2029)
  • 10.2.2 Middle East, Africa and Latin America Norovirus Vaccine Revenue by Application (2018-2029)
• 10.3 Middle East, Africa and Latin America Norovirus Vaccine Sales by Country
  • 10.3.1 Middle East, Africa and Latin America Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
  • 10.3.2 Middle East, Africa and Latin America Norovirus Vaccine Revenue by Country (2018-2029)
  • 10.3.3 Middle East, Africa and Latin America Norovirus Vaccine Sales by Country (2018-2029)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Company Profiles

• 11.1 Hillevax
  • 11.1.1 Hillevax Company Information
  • 11.1.2 Hillevax Overview
  • 11.1.3 Hillevax Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.1.4 Hillevax Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Hillevax Recent Developments
• 11.2 Vaxart
  • 11.2.1 Vaxart Company Information
  • 11.2.2 Vaxart Overview
  • 11.2.3 Vaxart Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.2.4 Vaxart Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Vaxart Recent Developments
• 11.3 Moderna
  • 11.3.1 Moderna Company Information
  • 11.3.2 Moderna Overview
  • 11.3.3 Moderna Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.3.4 Moderna Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Moderna Recent Developments
• 11.4 UMN Pharma
  • 11.4.1 UMN Pharma Company Information
  • 11.4.2 UMN Pharma Overview
  • 11.4.3 UMN Pharma Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.4.4 UMN Pharma Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 UMN Pharma Recent Developments
• 11.5 Daiichi Sankyo
  • 11.5.1 Daiichi Sankyo Company Information
  • 11.5.2 Daiichi Sankyo Overview
  • 11.5.3 Daiichi Sankyo Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.5.4 Daiichi Sankyo Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Daiichi Sankyo Recent Developments
• 11.6 Kanghua Biology
  • 11.6.1 Kanghua Biology Company Information
  • 11.6.2 Kanghua Biology Overview
  • 11.6.3 Kanghua Biology Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.6.4 Kanghua Biology Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Kanghua Biology Recent Developments
• 11.7 Beijing Institute of Biological Products
  • 11.7.1 Beijing Institute of Biological Products Company Information
  • 11.7.2 Beijing Institute of Biological Products Overview
  • 11.7.3 Beijing Institute of Biological Products Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.7.4 Beijing Institute of Biological Products Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Beijing Institute of Biological Products Recent Developments
• 11.8 Zhifei Bio
  • 11.8.1 Zhifei Bio Company Information
  • 11.8.2 Zhifei Bio Overview
  • 11.8.3 Zhifei Bio Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.8.4 Zhifei Bio Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Zhifei Bio Recent Developments
• 11.9 China Biotechnology Co., Ltd.
  • 11.9.1 China Biotechnology Co., Ltd. Company Information
  • 11.9.2 China Biotechnology Co., Ltd. Overview
  • 11.9.3 China Biotechnology Co., Ltd. Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.9.4 China Biotechnology Co., Ltd. Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 China Biotechnology Co., Ltd. Recent Developments
• 11.10 North China Pharmaceutical
  • 11.10.1 North China Pharmaceutical Company Information
  • 11.10.2 North China Pharmaceutical Overview
  • 11.10.3 North China Pharmaceutical Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
  • 11.10.4 North China Pharmaceutical Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 North China Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Norovirus Vaccine Industry Chain Analysis
• 12.2 Norovirus Vaccine Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Norovirus Vaccine Production Mode & Process
• 12.4 Norovirus Vaccine Sales and Marketing
  • 12.4.1 Norovirus Vaccine Sales Channels
  • 12.4.2 Norovirus Vaccine Distributors
• 12.5 Norovirus Vaccine Customers

13 Market Dynamics

• 13.1 Norovirus Vaccine Industry Trends
• 13.2 Norovirus Vaccine Market Drivers
• 13.3 Norovirus Vaccine Market Challenges
• 13.4 Norovirus Vaccine Market Restraints

14 Key Findings in The Global Norovirus Vaccine Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

• Table 1. Global Norovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of Bivalent
• Table 3. Major Manufacturers of Quadrivalent
• Table 4. Major Manufacturers of Hexavalent
• Table 5. Global Norovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 6. Global Norovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 7. Global Norovirus Vaccine Revenue by Region (2018-2023) & (US$ Million)
• Table 8. Global Norovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
• Table 9. Global Norovirus Vaccine Revenue Market Share by Region (2018-2023)
• Table 10. Global Norovirus Vaccine Revenue Market Share by Region (2024-2029)
• Table 11. Global Norovirus Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 12. Global Norovirus Vaccine Sales by Region (2018-2023) & (K Units)
• Table 13. Global Norovirus Vaccine Sales by Region (2024-2029) & (K Units)
• Table 14. Global Norovirus Vaccine Sales Market Share by Region (2018-2023)
• Table 15. Global Norovirus Vaccine Sales Market Share by Region (2024-2029)
• Table 16. Global Norovirus Vaccine Sales by Manufacturers (2018-2023) & (K Units)
• Table 17. Global Norovirus Vaccine Sales Share by Manufacturers (2018-2023)
• Table 18. Global Norovirus Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 19. Global Norovirus Vaccine Revenue Share by Manufacturers (2018-2023)
• Table 20. Global Key Players of Norovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
• Table 21. Norovirus Vaccine Price by Manufacturers 2018-2023 (US$/Unit)
• Table 22. Global Norovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 23. Global Norovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Norovirus Vaccine as of 2022)
• Table 24. Global Key Manufacturers of Norovirus Vaccine, Manufacturing Base Distribution and Headquarters
• Table 25. Global Key Manufacturers of Norovirus Vaccine, Product Offered and Application
• Table 26. Global Key Manufacturers of Norovirus Vaccine, Date of Enter into This Industry
• Table 27. Mergers & Acquisitions, Expansion Plans
• Table 28. Global Norovirus Vaccine Sales by Type (2018-2023) & (K Units)
• Table 29. Global Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
• Table 30. Global Norovirus Vaccine Sales Share by Type (2018-2023)
• Table 31. Global Norovirus Vaccine Sales Share by Type (2024-2029)
• Table 32. Global Norovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 33. Global Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 34. Global Norovirus Vaccine Revenue Share by Type (2018-2023)
• Table 35. Global Norovirus Vaccine Revenue Share by Type (2024-2029)
• Table 36. Norovirus Vaccine Price by Type (2018-2023) & (US$/Unit)
• Table 37. Global Norovirus Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
• Table 38. Global Norovirus Vaccine Sales by Application (2018-2023) & (K Units)
• Table 39. Global Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
• Table 40. Global Norovirus Vaccine Sales Share by Application (2018-2023)
• Table 41. Global Norovirus Vaccine Sales Share by Application (2024-2029)
• Table 42. Global Norovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 43. Global Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 44. Global Norovirus Vaccine Revenue Share by Application (2018-2023)
• Table 45. Global Norovirus Vaccine Revenue Share by Application (2024-2029)
• Table 46. Norovirus Vaccine Price by Application (2018-2023) & (US$/Unit)
• Table 47. Global Norovirus Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
• Table 48. US & Canada Norovirus Vaccine Sales by Type (2018-2023) & (K Units)
• Table 49. US & Canada Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
• Table 50. US & Canada Norovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 51. US & Canada Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 52. US & Canada Norovirus Vaccine Sales by Application (2018-2023) & (K Units)
• Table 53. US & Canada Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
• Table 54. US & Canada Norovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 55. US & Canada Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 56. US & Canada Norovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 57. US & Canada Norovirus Vaccine Revenue by Country (2018-2023) & (US$ Million)
• Table 58. US & Canada Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
• Table 59. US & Canada Norovirus Vaccine Sales by Country (2018-2023) & (K Units)
• Table 60. US & Canada Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
• Table 61. Europe Norovirus Vaccine Sales by Type (2018-2023) & (K Units)
• Table 62. Europe Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
• Table 63. Europe Norovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 64. Europe Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 65. Europe Norovirus Vaccine Sales by Application (2018-2023) & (K Units)
• Table 66. Europe Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
• Table 67. Europe Norovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 68. Europe Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 69. Europe Norovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 70. Europe Norovirus Vaccine Revenue by Country (2018-2023) & (US$ Million)
• Table 71. Europe Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
• Table 72. Europe Norovirus Vaccine Sales by Country (2018-2023) & (K Units)
• Table 73. Europe Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
• Table 74. China Norovirus Vaccine Sales by Type (2018-2023) & (K Units)
• Table 75. China Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
• Table 76. China Norovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 77. China Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 78. China Norovirus Vaccine Sales by Application (2018-2023) & (K Units)
• Table 79. China Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
• Table 80. China Norovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 81. China Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 82. Asia Norovirus Vaccine Sales by Type (2018-2023) & (K Units)
• Table 83. Asia Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
• Table 84. Asia Norovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 85. Asia Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 86. Asia Norovirus Vaccine Sales by Application (2018-2023) & (K Units)
• Table 87. Asia Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
• Table 88. Asia Norovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 89. Asia Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 90. Asia Norovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 91. Asia Norovirus Vaccine Revenue by Region (2018-2023) & (US$ Million)
• Table 92. Asia Norovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
• Table 93. Asia Norovirus Vaccine Sales by Region (2018-2023) & (K Units)
• Table 94. Asia Norovirus Vaccine Sales by Region (2024-2029) & (K Units)
• Table 95. Middle East, Africa and Latin America Norovirus Vaccine Sales by Type (2018-2023) & (K Units)
• Table 96. Middle East, Africa and Latin America Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
• Table 97. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
• Table 98. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
• Table 99. Middle East, Africa and Latin America Norovirus Vaccine Sales by Application (2018-2023) & (K Units)
• Table 100. Middle East, Africa and Latin America Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
• Table 101. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
• Table 103. Middle East, Africa and Latin America Norovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 104. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Country (2018-2023) & (US$ Million)
• Table 105. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Norovirus Vaccine Sales by Country (2018-2023) & (K Units)
• Table 107. Middle East, Africa and Latin America Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
• Table 108. Hillevax Company Information
• Table 109. Hillevax Description and Major Businesses
• Table 110. Hillevax Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 111. Hillevax Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 112. Hillevax Recent Developments
• Table 113. Vaxart Company Information
• Table 114. Vaxart Description and Major Businesses
• Table 115. Vaxart Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 116. Vaxart Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 117. Vaxart Recent Developments
• Table 118. Moderna Company Information
• Table 119. Moderna Description and Major Businesses
• Table 120. Moderna Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 121. Moderna Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 122. Moderna Recent Developments
• Table 123. UMN Pharma Company Information
• Table 124. UMN Pharma Description and Major Businesses
• Table 125. UMN Pharma Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 126. UMN Pharma Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 127. UMN Pharma Recent Developments
• Table 128. Daiichi Sankyo Company Information
• Table 129. Daiichi Sankyo Description and Major Businesses
• Table 130. Daiichi Sankyo Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 131. Daiichi Sankyo Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 132. Daiichi Sankyo Recent Developments
• Table 133. Kanghua Biology Company Information
• Table 134. Kanghua Biology Description and Major Businesses
• Table 135. Kanghua Biology Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 136. Kanghua Biology Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 137. Kanghua Biology Recent Developments
• Table 138. Beijing Institute of Biological Products Company Information
• Table 139. Beijing Institute of Biological Products Description and Major Businesses
• Table 140. Beijing Institute of Biological Products Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 141. Beijing Institute of Biological Products Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 142. Beijing Institute of Biological Products Recent Developments
• Table 143. Zhifei Bio Company Information
• Table 144. Zhifei Bio Description and Major Businesses
• Table 145. Zhifei Bio Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 146. Zhifei Bio Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 147. Zhifei Bio Recent Developments
• Table 148. China Biotechnology Co., Ltd. Company Information
• Table 149. China Biotechnology Co., Ltd. Description and Major Businesses
• Table 150. China Biotechnology Co., Ltd. Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 151. China Biotechnology Co., Ltd. Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 152. China Biotechnology Co., Ltd. Recent Developments
• Table 153. North China Pharmaceutical Company Information
• Table 154. North China Pharmaceutical Description and Major Businesses
• Table 155. North China Pharmaceutical Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
• Table 156. North China Pharmaceutical Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
• Table 157. North China Pharmaceutical Recent Developments
• Table 158. Key Raw Materials Lists
• Table 159. Raw Materials Key Suppliers Lists
• Table 160. Norovirus Vaccine Distributors List
• Table 161. Norovirus Vaccine Customers List
• Table 162. Norovirus Vaccine Market Trends
• Table 163. Norovirus Vaccine Market Drivers
• Table 164. Norovirus Vaccine Market Challenges
• Table 165. Norovirus Vaccine Market Restraints
• Table 166. Research Programs/Design for This Report
• Table 167. Key Data Information from Secondary Sources
• Table 168. Key Data Information from Primary Sources

List of Figures

• Figure 1. Norovirus Vaccine Product Picture
• Figure 2. Global Norovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Norovirus Vaccine Market Share by Type in 2022 & 2029
• Figure 4. Bivalent Product Picture
• Figure 5. Quadrivalent Product Picture
• Figure 6. Hexavalent Product Picture
• Figure 7. Global Norovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 8. Global Norovirus Vaccine Market Share by Application in 2022 & 2029
• Figure 9. Hospital
• Figure 10. Clinic
• Figure 11. Others
• Figure 12. Norovirus Vaccine Report Years Considered
• Figure 13. Global Norovirus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 14. Global Norovirus Vaccine Revenue 2018-2029 (US$ Million)
• Figure 15. Global Norovirus Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 16. Global Norovirus Vaccine Revenue Market Share by Region (2018-2029)
• Figure 17. Global Norovirus Vaccine Sales 2018-2029 ((K Units)
• Figure 18. Global Norovirus Vaccine Sales Market Share by Region (2018-2029)
• Figure 19. US & Canada Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 20. US & Canada Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 21. Europe Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 22. Europe Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 23. China Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 24. China Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 25. Asia (excluding China) Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 26. Asia (excluding China) Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 27. Middle East, Africa and Latin America Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
• Figure 28. Middle East, Africa and Latin America Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
• Figure 29. The Norovirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 30. The Top 5 and 10 Largest Manufacturers of Norovirus Vaccine in the World: Market Share by Norovirus Vaccine Revenue in 2022
• Figure 31. Global Norovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 32. Global Norovirus Vaccine Sales Market Share by Type (2018-2029)
• Figure 33. Global Norovirus Vaccine Revenue Market Share by Type (2018-2029)
• Figure 34. Global Norovirus Vaccine Sales Market Share by Application (2018-2029)
• Figure 35. Global Norovirus Vaccine Revenue Market Share by Application (2018-2029)
• Figure 36. US & Canada Norovirus Vaccine Sales Market Share by Type (2018-2029)
• Figure 37. US & Canada Norovirus Vaccine Revenue Market Share by Type (2018-2029)
• Figure 38. US & Canada Norovirus Vaccine Sales Market Share by Application (2018-2029)
• Figure 39. US & Canada Norovirus Vaccine Revenue Market Share by Application (2018-2029)
• Figure 40. US & Canada Norovirus Vaccine Revenue Share by Country (2018-2029)
• Figure 41. US & Canada Norovirus Vaccine Sales Share by Country (2018-2029)
• Figure 42. U.S. Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 43. Canada Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 44. Europe Norovirus Vaccine Sales Market Share by Type (2018-2029)
• Figure 45. Europe Norovirus Vaccine Revenue Market Share by Type (2018-2029)
• Figure 46. Europe Norovirus Vaccine Sales Market Share by Application (2018-2029)
• Figure 47. Europe Norovirus Vaccine Revenue Market Share by Application (2018-2029)
• Figure 48. Europe Norovirus Vaccine Revenue Share by Country (2018-2029)
• Figure 49. Europe Norovirus Vaccine Sales Share by Country (2018-2029)
• Figure 50. Germany Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 51. France Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 52. U.K. Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 53. Italy Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 54. Russia Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 55. China Norovirus Vaccine Sales Market Share by Type (2018-2029)
• Figure 56. China Norovirus Vaccine Revenue Market Share by Type (2018-2029)
• Figure 57. China Norovirus Vaccine Sales Market Share by Application (2018-2029)
• Figure 58. China Norovirus Vaccine Revenue Market Share by Application (2018-2029)
• Figure 59. Asia Norovirus Vaccine Sales Market Share by Type (2018-2029)
• Figure 60. Asia Norovirus Vaccine Revenue Market Share by Type (2018-2029)
• Figure 61. Asia Norovirus Vaccine Sales Market Share by Application (2018-2029)
• Figure 62. Asia Norovirus Vaccine Revenue Market Share by Application (2018-2029)
• Figure 63. Asia Norovirus Vaccine Revenue Share by Region (2018-2029)
• Figure 64. Asia Norovirus Vaccine Sales Share by Region (2018-2029)
• Figure 65. Japan Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 66. South Korea Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 67. China Taiwan Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 68. Southeast Asia Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 69. India Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 70. Middle East, Africa and Latin America Norovirus Vaccine Sales Market Share by Type (2018-2029)
• Figure 71. Middle East, Africa and Latin America Norovirus Vaccine Revenue Market Share by Type (2018-2029)
• Figure 72. Middle East, Africa and Latin America Norovirus Vaccine Sales Market Share by Application (2018-2029)
• Figure 73. Middle East, Africa and Latin America Norovirus Vaccine Revenue Market Share by Application (2018-2029)
• Figure 74. Middle East, Africa and Latin America Norovirus Vaccine Revenue Share by Country (2018-2029)
• Figure 75. Middle East, Africa and Latin America Norovirus Vaccine Sales Share by Country (2018-2029)
• Figure 76. Brazil Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 77. Mexico Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 78. Turkey Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 79. Israel Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 80. GCC Countries Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
• Figure 81. Norovirus Vaccine Value Chain
• Figure 82. Norovirus Vaccine Production Process
• Figure 83. Channels of Distribution
• Figure 84. Distributors Profiles
• Figure 85. Bottom-up and Top-down Approaches for This Report
• Figure 86. Data Triangulation
• Figure 87. Key Executives Interviewed